|
|
Article: Investigators at St. Mary's Hospital publish new data on obstetrics.(Clinical report)
- Article from:
- Women's Health Weekly
- Article date:
- November 12, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Fresh data on obstetrics are presented in the report 'A randomised, double-blinded, placebo-controlled study of the phosphodiesterase type 5 inhibitor sildenafil for the treatment of preeclampsia.' According to a study from Manchester, the United Kingdom, "To determine if the phosphodiesterase type 5 inhibitor sildenafil prolongs pregnancy in women with preeclampsia. Women with preeclampsia at gestational ages 24-34 weeks were recruited from nine hospitals in the UK, and randomly assigned to sildenafil citrate or placebo."
"Medication was increased every 3 days from 20 mg three times daily (tid), to 40 mg, and 80 mg tid. The primary endpoint was prolongation of ...
Related newspaper, magazine, and journal articles:
|
|
Article: Studies from A. Grosso et al in the area of adverse ...
Blood Weekly;
December 18, 2008 ;
700+ words
... ... researchers in London, the United Kingdom report (see also Adverse Drug Reactions). "We ... early detection of adverse drug reactions. British ... England. Keywords: United Kingdom, London, Adverse Drug Reactions, Adverse ...
|
|